The high price of cancer drugs in the US relative to European countries with universal health care raises ethical issues of access, financial burden on patients, and unsustainability of the health care system.
AMA J Ethics. 2015;17(8):750-753. doi:
10.1001/journalofethics.2015.17.8.nlit1-1508.
Physicians will have a greater impact on health if they advocate for changes needed to prevent illness and harm than if they simply patch up those who are sick or harmed.
Physicians who base end-of-life care decisions for patients on their own preferences may offer less treatment than the patients themselves would have wanted.